secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cencora, Inc. (COR)
CIK:        0001140859
Form:       8-K
Filed at:   2026-02-04T23:59:59+00:00
Accession:  0001140859-26-000004
Event type: earnings
Sentiment:  positive
Materiality: 0.90
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cencora Q1 EPS $2.87 GAAP, $4.08 adjusted; acquires OneOncology for $4.6B
-------------------------------------------------------------------------

- Revenue $85.9B, +5.5% YoY; GAAP diluted EPS $2.87 vs $2.50 prior year; adjusted diluted EPS $4.08 vs $3.73, +9.4%.
- Completed acquisition of OneOncology on Feb 2 for ~$4.6B in cash funded by new debt; operations consolidated in U.S. Healthcare Solutions.
- Adjusted operating income guidance raised to growth of 11.5%-13.5% from prior 8%-10%; adjusted EPS guidance reaffirmed at $17.45-$17.75.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1140859/000114085926000004/0001140859-26-000004-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1140859/000114085926000004/abc-20260202.htm
  HTML page:      https://secwatch.observer/filing/0001140859-26-000004

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer